
KLOW
Research peptide blend containing GHK-Cu, TB-500, BPC-157 and KPV. Supplied as an 80mg lyophilised vial for laboratory research workflows.
PayPal or cash on collection · UK 18+ verification at checkout · For laboratory research use only
Frequently bought together
Full catalogue →
MOTS‑C
Mitochondrial‑derived peptide. Studied in preclinical research on AMPK activation and metabolic‑regulation pathways.

Tesamorelin
GHRH analogue. Studied in clinical research on growth‑hormone secretion and visceral‑adiposity endpoints.

Ipamorelin
Selective GH secretagogue studied for low cortisol and prolactin involvement in research models. A selective GH‑releasing research peptide.

GLP1‑TRIPLE (Reta)
Triple agonist (GLP‑1/GIP/glucagon receptor). Studied in preclinical metabolic research.
Often stacked with KLOW
Full catalogue →
GHK‑Cu
Copper peptide naturally occurring in plasma. Studied in preclinical research on skin remodelling, wound‑repair pathways, and gene‑expression modulation. Referenced in cellular‑senescence research groupings.

TB‑500
Synthetic thymosin beta‑4 fragment. Studied in preclinical models examining wound‑repair and cell‑migration pathways. Frequently referenced alongside BPC‑157 in research.

BPC‑157
Gastric pentadecapeptide. Studied in preclinical models of tissue repair and gastrointestinal research.

KPV
Tripeptide derived from alpha‑MSH. Studied in preclinical anti‑inflammatory and gastrointestinal research. Commonly referenced in research‑compound groupings.
